Abstract
Liraglutide is an agonist of the glucagon-like peptide I receptor, and is commonly recommended as a treatment for obesity and type 2 diabetes mellitus. Adverse effects related to liraglutide include acute pancreatitis and polyarthritis. No studies, however, have reported an adverse effect of liraglutide on male reproduction. This case report shows a deleterious effect of liraglutide on male reproductive function.
Keywords:
liraglutide; male infertility; male reproduction; spermatozoa.
Copyright © 2014 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.
Publication types
-
Case Reports
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adult
-
Diabetes Mellitus, Type 2 / complications
-
Diabetes Mellitus, Type 2 / drug therapy
-
Female
-
Fertility / drug effects*
-
Glucagon-Like Peptide 1 / adverse effects
-
Glucagon-Like Peptide 1 / analogs & derivatives*
-
Humans
-
Hypoglycemic Agents / adverse effects*
-
Infertility, Male / chemically induced*
-
Liraglutide
-
Male
-
Obesity / complications
-
Obesity / drug therapy
-
Pregnancy
-
Pregnancy Outcome
-
Sperm Count
-
Sperm Injections, Intracytoplasmic
-
Sperm Motility / drug effects
-
Spermatozoa / drug effects
Substances
-
Hypoglycemic Agents
-
Liraglutide
-
Glucagon-Like Peptide 1